alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Nutrastar International Inc.: Exhibit 10.1 - Filed by newsfilecorp.com






AMENDMENT NUMBER 3 TO EMPLOYEE LABOR AGREEMENT 

THIS AMENDMENT NUMBER 3 TO EMPLOYEE LABOR AGREEMENT, dated as
of August 12, 2014 (this “Amendment”), is entered into by and between Nutrastar
International Inc., a Nevada corporation (the “Company”) and Robert Tick (the
“Employee”). 

WHEREAS, the Company and the Employee are parties to
that certain Employee Labor Agreement, dated as of July 16, 2010 (the
“Employment Agreement”), Amendment Number 1 to the Employee Labor Agreement,
dated as of January 24, 2011 and Amendment Number 2 to the Employee Labor
Agreement, dated as of August 8, 2013 (“Amendments 1 & 2”). The parties to
this Amendment desire to amend the Employment Agreement and Amendments 1 &
2, as set forth in this Amendment. 

NOW, THEREFORE, in consideration of the foregoing and
the respective covenants and agreements set forth herein, the parties hereto
agree as follows:

SECTION 1. Amendment. 

Section 2 of the Employment Agreement is hereby
deleted and shall be replaced with the following language: 

	 	2. 	
      Term: The term of the Employment Agreement shall be “at
      will”, meaning that either you or the Company will be entitled to
      terminate the Employment Agreement at any time, with a ninety (90 days)
      advance written notice.



Sections 3A of the Employment Agreement are hereby
deleted and shall be replaced with the following language: 

	 	3. 	
      Salary and Bonus

	 	 	 	 
	 		A. 	
      You monthly base salary effective July 1, 2014 is
      US$17,000 and shall be paid at the last day of each month to the bank
      account designated by you.



SECTION 2. Full Force and Effect. All other
provisions of the Employment Agreement not specifically amended in this
Amendment shall remain in full force and effect.

SECTION 3. Governing Law. This Amendment shall be
governed by and construed in accordance with the laws of the State of
Nevada.

SECTION 4. Entire Agreement. This Amendment along
with the Employment Agreement and Amendments 1 & 2 contains the entire
understanding of the parties with respect to the subject matter hereof and
supersedes all prior agreements, understandings, discussions and
representations, oral or written, with respect to such matters, which the
parties acknowledge have been merged into this Amendment.




SECTION 5. Counterparts. This Amendment may be
executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument.

[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK] 




IN WITNESS WHEREOF, the parties hereto have caused this
Amendment to be duly executed by their respective authorized signatories as of
the date first indicated above.

 

COMPANY: 

NUTRASTAR INTERNATIONAL INC. 

By: 

	/s/ Lianyun Han
	 
	Name: Lianyun Han 	 
	Title: Chief Executive Officer 	 
	  	 
	EMPLOYEE: 	 
	  	 
	/s/ Robert Tick
	 
	Name: Robert Tick
| (1)   | the      quarterly Report on Form 10-Q of Vortec Electronics, Inc. for the quarter      ended January 31, 2009 fully complies with the requirements of Section      13(a) or 15(d) of the Securities Exchange Act of 1934;  and |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | the      information contained in the quarterly Report on Form 10-Q for the quarter      ended January 31, 2009, fairly presents in all material respects, the      financial condition and results of operations of Vortec Electronics,      Inc. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  By:    |  /s/ Melissa      Lopez                                                          |
|--------------|---------------------------------------------------------------------------------------|
|  Name:  |  Melissa      Lopez                                                              |
|  Title: |  Principal      Executive Officer, Principal      Financial Officer and Director |
|  Date:  |  March      9, 2009                                                              |
Exhibit 32.1

Certification of Principal Executive Officer

Pursuant to 18 U.S.C. § 1350, as created by
Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of MAP Pharmaceuticals, Inc., a Delaware corporation (the Company), hereby certifies, to his knowledge, that:

(i) the accompanying Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2009 (the Report) fully complies
with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/    TIMOTHY S. NELSONTimothy S. Nelson President, Chief Executive Officer
and Director (Principal Executive Officer)


Dated: May 8, 2009

A signed original of this written statement required by Section 906 has been provided to MAP Pharmaceuticals, Inc. and will be retained by MAP Pharmaceuticals, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.

Certification of Principal Financial Officer

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of MAP Pharmaceuticals,
Inc., a Delaware corporation (the Company), hereby certifies, to his knowledge, that:

(i) the accompanying Quarterly Report
on Form 10-Q of the Company for the period ended March 31, 2009 (the Report) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.

/s/    CHRISTOPHER Y. CHAIChristopher Y. ChaiChief Financial Officer(Principal Financial Officer)


Dated: May 8, 2009

A signed original of this written statement required by Section 906 has been provided to MAP Pharmaceuticals, Inc. and will be retained by MAP Pharmaceuticals, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.
Exhibit 32.2

Certification of Chief Financial Officer pursuant to  18 U.S.C. Section 1350,  as adopted pursuant to  Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Pzena Investment Management, Inc. (the "Company") for
the quarter ending June 30, 2008, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Wayne A. Palladino, as Chief Financial Officer of the Company
certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



Dated: August 13, 2008

/s/WAYNE A. PALLADINOName: Wayne A. Palladino
Title:Chief Financial Officer


---



QuickLinks
# L_2012287EN.01001101.xml

| 18.10.2012 | EN | Official Journal of the European Union | L 287/11 |
| --- | --- | --- | --- |

18.10.2012

EN

Official Journal of the European Union

L 287/11

---

COUNCIL DECISION

of 16 October 2012

appointing a German member of the Committee of the Regions

(2012/647/EU)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 305 thereof,

Having regard to the proposal of the German Government,

Whereas:

| (1) | On 22 December 2009 and on 18 January 2010, the Council adopted Decisions 2009/1014/EU (1) and 2010/29/EU (2) appointing the members and alternate members of the Committee of the Regions for the period from 26 January 2010 to 25 January 2015. |
| --- | --- |

(1)

On 22 December 2009 and on 18 January 2010, the Council adopted Decisions 2009/1014/EU (1) and 2010/29/EU (2) appointing the members and alternate members of the Committee of the Regions for the period from 26 January 2010 to 25 January 2015.

| (2) | A member’s seat on the Committee of the Regions has become vacant following the end of the term of office of Ms Petra ROTH, |
| --- | --- |

(2)

A member’s seat on the Committee of the Regions has become vacant following the end of the term of office of Ms Petra ROTH,

HAS ADOPTED THIS DECISION:

Article 1

The following is hereby appointed as member to the Committee of the Regions for the remainder of the current term of office, which runs until 25 January 2015:

| — | Ms Dagmar MÜHLENFELD, Oberbürgermeisterin der Stadt Mülheim an der Ruhr. |
| --- | --- |

—

Ms Dagmar MÜHLENFELD, Oberbürgermeisterin der Stadt Mülheim an der Ruhr.

Article 2

This Decision shall enter into force on the day of its adoption.

Done at Luxembourg, 16 October 2012.

For the Council

The President

A. D. MAVROYIANNIS

---

(1)  
  OJ L 348, 29.12.2009, p. 22.

1

(2)  
  OJ L 12, 19.1.2010, p. 11.

2

---
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 06-7487

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

OVERTON WAYNE PAULEY,

Defendant - Appellant.

Appeal from the United States District Court for the Southern

District of West Virginia, at Charleston. John T. Copenhaver, Jr.,

District Judge. (2:99-cr-00048-6; 2:04-cv-00081)

Submitted: March 14, 2007 Decided: March 26, 2007

Before NIEMEYER and GREGORY, Circuit Judges, and HAMILTON, Senior

Circuit Judge.

Dismissed by unpublished per curiam opinion.

Overton Wayne Pauley, Appellant Pro Se. Kasey Warner, OFFICE OF

THE UNITED STATES ATTORNEY, Charleston, West Virginia, for

Appellee.

Unpublished opinions are not binding precedent in this circuit.
- 2 -

PER CURIAM:

Overton Wayne Pauley seeks to appeal the district court’s

order accepting the recommendation of the magistrate judge and

denying relief on his 28 U.S.C. § 2255 (2000) motion. The order is

not appealable unless a circuit justice or judge issues a

certificate of appealability. 28 U.S.C. § 2253(c)(1) (2000). A

certificate of appealability will not issue absent “a substantial

showing of the denial of a constitutional right.” 28 U.S.C.

§ 2253(c)(2) (2000). A prisoner satisfies this standard by

demonstrating that reasonable jurists would find that any

assessment of the constitutional claims by the district court is

debatable or wrong and that any dispositive procedural ruling by

the district court is likewise debatable. Miller-El v. Cockrell,

537 U.S. 322, 336-38 (2003); Slack v. McDaniel, 529 U.S. 473, 484

(2000); Rose v. Lee, 252 F.3d 676, 683-84 (4th Cir. 2001). We have

independently reviewed the record and conclude that Pauley has not

made the requisite showing. Accordingly, we deny a certificate of

appealability and dismiss the appeal. We dispense with oral

argument because the facts and legal contentions are adequately

presented in the materials before the court and argument would not

aid the decisional process.

DISMISSED
Exhibit 99.11

SRK
Consulting (Canada)
Inc.
1500, 155 University
Avenue
Toronto, Ontario,
Canada
M5H
3B7

T:
+1.416.601.1445
F:
+1.416.601.9046

toronto@srk.com
www.srk.com











CONSENT OF
ENGINEER








Ladies and
Gentlemen:





The undersigned hereby
consents to (1) the references to the undersigned’s name
included or incorporated by reference in the Annual Report on Form
40-F of Denison Mines Corp. in connection with the report entitled
(a) “Technical Report with an Updated Mineral Resource
Estimate for the Midwest Property, Northern Saskatchewan,
Canada” dated March 26, 2018, and (b) "Technical Report with
an Updated Mineral Resource Estimate for the Waterbury Lake
Property, Northern Saskatchewan" dated December 21, 2018, and (2)
all other references to the undersigned included or incorporated by
reference in the Annual Report on Form 40-F of Denison Mines
Corp.





Dated: March 13,
2019











(Signed) “Oy
Leuangthong”


__________________________


Oy
Leuangthong, PEng.


SRK
Consulting (Canada) Inc.


Local Offices:
Saskatoon
Sudbury
Toronto
Vancouver
Yellowknife
Group Offices:
Africa
Asia
Australia
Europe
North America
South America
(logo)Rialto

         CAPITAL

 

 

**2017Annual Statement of Servicer Compliance (Item 1123)**

 

Poolingand Servicing Agreement (the “Pooling and Servicing Agreement”) dated as of September1, 2012 by and among Wells Fargo Commercial Mortgage Securities, Inc. asDepositor, Wells Fargo Bank, National Association as Master Servicer, RialtoCapital Advisors, LLC as Special Servicer, TriMont Real Estate Advisors, Inc.as Trust Advisor, Wells Fargo Bank, National Association as CertificateAdministrator, as Tax Administrator and as Custodian and U.S. Bank NationalAssociation as Trustee relating to the Wells Fargo Commercial Mortgage Trust2012-LC5, Commercial Mortgage Pass-Through Certificates, Series 2012-LC5 **(WFCM2012-LC5)**

 

Theundersigned, a duly authorized officer of Rialto Capital Advisors, LLC, asspecial servicer (the “Special Servicer”) herein certifies to the following:

 

1.      All servicing activities and performance of such servicing activities under thePooling and Servicing Agreement are performed on behalf of the SpecialServicer.

 

2.      A review of the servicing activities and performance by the Special Servicerfor the period of January 1, 2017 to December 31, 2017 (the “Reporting Period”)in accordance with the Pooling and Servicing Agreement has been conducted undermy supervision.

 

3.      To the best of my knowledge, based on such review, the Special Servicer hasfulfilled all of its obligations under the terms of the Pooling and ServicingAgreement, in all material respects for the Reporting Period and if there hasbeen a failure to fulfill any such obligations in any material respect, eachfailure and the nature and status thereof has been specifically identifiedherein.

 

 

Certifiedby: /s/ AdamSinger                                                Date: March1, 2018

      AdamSinger, Managing Director
# L_2011293EN.01001901.xml

| 11.11.2011 | EN | Official Journal of the European Union | L 293/19 |
| --- | --- | --- | --- |

11.11.2011

EN

Official Journal of the European Union

L 293/19

---

COUNCIL REGULATION (EU) No 1139/2011

of 10 November 2011

amending Regulation (EU) No 204/2011 concerning restrictive measures in view of the situation in Libya

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 215 thereof,

Having regard to Council Decision 2011/729/CFSP of 10 November 2011 amending Decision 2011/137/CFSP concerning restrictive measures in view of the situation in Libya (1),

Having regard to the joint proposal from the High Representative of the Union for Foreign Affairs and Security Policy and the European Commission,

Whereas:

| (1) | By Resolution 1973 (2011) of 17 March 2011, the United Nations Security Council (UNSC) decided that a ban should be imposed on flights in the airspace of Libya. |
| --- | --- |

(1)

By Resolution 1973 (2011) of 17 March 2011, the United Nations Security Council (UNSC) decided that a ban should be imposed on flights in the airspace of Libya.

| (2) | In application of Council Decision 2011/137/CFSP (2), that ban was given effect in the European Union by Regulation (EU) No 204/2011 of 2 March 2011 concerning restrictive measures in view of the situation in Libya (3). |
| --- | --- |

(2)

In application of Council Decision 2011/137/CFSP (2), that ban was given effect in the European Union by Regulation (EU) No 204/2011 of 2 March 2011 concerning restrictive measures in view of the situation in Libya (3).

| (3) | By Resolution 2016 (2011) of 27 October 2011, the UNSC decided that the ban should be terminated. |
| --- | --- |

(3)

By Resolution 2016 (2011) of 27 October 2011, the UNSC decided that the ban should be terminated.

| (4) | Following Decision 2011/729/CFSP, the provision of Regulation (EU) No 204/2011 imposing the ban on flights should therefore be repealed, |
| --- | --- |

(4)

Following Decision 2011/729/CFSP, the provision of Regulation (EU) No 204/2011 imposing the ban on flights should therefore be repealed,

HAS ADOPTED THIS REGULATION:

Article 1

Article 4b of Regulation (EU) No 204/2011 is hereby deleted.

Article 2

This Regulation shall enter into force on the day of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 10 November 2011.

For the Council

The President

M. DOWGIELEWICZ

---

(1)  See page 35 of this Official Journal.

1

(2)  
  OJ L 58, 3.3.2011, p. 53.

2

(3)  
  OJ L 58. 3.3.2011, p. 1.

3

---
#### GAMMONS v. STATE.

No. 19289.

Court of Criminal Appeals of Texas.

Jan. 12, 1938.

'Earl M. Greer, of Wills Point, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

MORROW, Presiding Judge.

The offense is rape; penalty assessed at confinement in the penitentiary for ten years.

The indictment appears regular. The record is before this court without statement of facts or bills of exception. No error has been perceived which would justify a reversal of the conviction or require further discussion.

The judgment is affirmed.
##### 



CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
    /s/ Michael O. Aldridge

Michael O. AldridgeChief Financial OfficerNovember 6, 2007
ANALYTICAL AL-2010-000534

Analytical Report Lab Report Code

AL-2010-000534

Date Issued

15-Jan-2010

Department Geographic Location Raw Data References Report Status

Analytical Final

Title

Measurement of the Molecular Weight and Infrared Spectrum of 

Requested By Requested Date

12-Jan-2010

Author(s)

1

Reviewer(s)

Summary

submitted a sample of , for determination of its molecular weight and infrared 

spectrum. The molecular weight was determined using conventional size-exclusion chromatography (SEC). 

Results are based on calibration with . The sample was determined to have a 

. A distribution plot appears in Figure 1. Tables 1 – 16 report the sample’s molecular weight and peak height 

by retention time. Figure 2 shows the infrared spectrum; band assignments are listed in Table 17.

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

2

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

3

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

4

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

5

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

CONFIDENTIA 6L

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

7

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

8

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

9

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

10

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

11

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

12

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

13

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

CONFIDENTIA 14 L

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

15

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

16

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

CONFIDENTIA 17 L

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

18

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

19

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

20

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

21

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215 
ANALYTICAL AL-2010-000534

22

CONFIDENTIAL

BUSINESS INFORMATION

40 CFR 2.201 - 2.215
Exhibit 31.2

Certification by the Chief Financial Officer

pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as

adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Eric W. Evans, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q
of Patheon Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officer and
I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) or the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) [Paragraph omitted in accordance with Exchange Act Rule 13a-14(a);

(c) Evaluated
the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and

(d) Disclosed in this report any change in the registrants internal control over financial reporting
that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants
internal control over financial reporting; and

5. The registrants other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal
control over financial reporting.

Date: June 10, 2011



|                             
|-----------------------------
|/s/ Eric W. Evans            
|Eric W. Evans                
|Chief Financial Officer      
|(Principal Financial Officer)